Artwork for podcast A Call to Lead @LifeScience ORG
Danuta Jeziorska, Uncover Therapeutics
Episode 718th June 2026 • A Call to Lead @LifeScience ORG • LifeScience ORG
00:00:00 00:38:48

Share Episode

Shownotes

How does a cancer diagnosis completely rewire your leadership style?

Why is maintaining your mindset a core responsibility of a CEO?

And what is the question every leader should ask themselves before they make a decision?

Today I’m joined by Danuta Jeziorska, the former CEO and co-founder of Nucleome and current CEO and co-founder of Uncover Therapeutics based in Oxford. Uncover is an immuno-oncology company turning cancer’s immunoshield into an immunobeacon.

And we’ll get more into the science of that towards the end of the episode.

About LifeScience ORG

It’s no secret that Europe is a global leader in generating translational science. We’re grateful at LifeScience ORG to have a community of over 400 life science CEOs – leaders driving change in biotech, medtech, techBio and healthcare.

The conversations inside our community – stories of conviction, navigating challenges, and making bold decisions – inspire us every week. To hear the stories, lessons, and experiences of our life science leaders, listen to A Call to Lead @ LifeScience ORG, available on all good podcasting platforms.

Chapters

0:58 — Fascination With the Code of Life

5:06 — The CV in the Suitcase

12:54 — From the Lab to the Boardroom

17:20 — A Pandemic, a Diagnosis and a Company to Run

21:03 — Leading From Purpose Not Fear

25:26 — The CEO's Most Underrated Responsibility

30:48 — Why She Said Yes to Oncology

32:34 — What Europe Must Do Differently

Chapters

Video

More from YouTube